Table 2 Before-and-after analysis based on repeated cross-sectional surveys investigating the consultation process: effect of m RDT implementation on the main outcomes.
Before m RDT implementation Total patients = 937 | After m RDT implementation Total patients = 954 | Risk ratio(accounting for clustering) | ||||
|---|---|---|---|---|---|---|
n* | % (95% CI) | n* | % (95% CI) | Risk ratio (95% CI) | p-value | |
Effect of mRDT implementation on anti-malarial treatment | ||||||
Patients treated with anti-malarials | ||||||
All patients | 894 | 75% (72-78) | 912 | 20% (17-22) | 0.23 (0.20 - 0.26) | < 0.001 |
Patients complaining of fever | 755 | 81% (79-84) | 682 | 24% (20-27) | 0.25 (0.22 - 0.29) | < 0.001 |
Patients not complaining of fever | 139 | 42% (33-50) | 230 | 7% (4-11) | 0.16 (0.10 - 0.27) | < 0.001 |
Effect of mRDT implementation on adherence to malaria test result | ||||||
Patients treated with anti-malarials | ||||||
Patients with a positive malaria test | 370 | 99% (99-100) | 126 | 99% (98-100) | 1.00 (0.98 - 1.01) | 0.8 |
Patients with a negative malaria test | 215 | 53% (47-60) | 628 | 7% (5-9) | 0.09 (0.06 - 0.13) | <0.001 |
Effect of mRDT implementation on selection for malaria testing | ||||||
Patients tested for malaria | ||||||
All patients | 937 | 68% (65-71) | 954 | 83% (81-85) | 1.26 (1.19 - 1.33) | <0.001 |
Patients complaining of fever | 782 | 71% (68-74) | 717 | 91% (89-93) | 1.31 (1.25 - 1.36) | <0.001 |
Patients not complaining of fever | 155 | 49% (41-57) | 237 | 58% (52-65) | 1.21 (0.99 - 1.48) | 0.06 |
Effect of mRDT implementation on antibiotic treatment | ||||||
Patients treated with antibiotics | ||||||
All patients | 894 | 49% (46-53) | 912 | 72% (69-75) | 1.47 (1.37 - 1.59) | <0.001 |
Patients complaining of fever | 755 | 49% (45-52) | 682 | 73% (69-76) | 1.50 (1.38 - 1.63) | <0.001 |
Patients not complaining of fever | 139 | 52% (43-60) | 230 | 71% (65-77) | 1.38 (1.16 - 1.65) | <0.001 |
Patients with a positive malaria test | 370 | 37% (32-42) | 126 | 35% (26-43) | 0.91 (0.68 - 1.21) | 0.5 |
Patients with a negative malaria test | 215 | 54% (47-61) | 628 | 78% (75-81) | 1.45 (1.28 - 1.65) | <0.001 |
Effect of mRDT implementation on other laboratory tests than malaria | ||||||
Patient tested for urine infection | 937 | 7% (6-9) | 954 | 13% (11-15) | 1.74 (1.31 - 2.31) | <0.001 |
Patient tested for typhoid (Widal) | 937 | 2% (1-2) | 954 | 1% (1-2) | 0.76 (0.36 - 1.63) | 0.5 |
Patient tested for stool parasites | 937 | 6% (5-8) | 954 | 7% (6-9) | 1.13 (0.81 - 1.59) | 0.5 |